Short report: Mannose-binding lectin and toll-like receptor polymorphisms and chagas disease in Chile

American Journal of Tropical Medicine and Hygiene

Volumn 86, Issue 2, 2012, Pages 229-232

  Weitzel, Thomas ^a   Zulantay, Inés ^b   Danquah, Ina ^c   Hamann, Lutz ^d   Schumann, Ralf R ^d   Apt, Werner ^b   Mockenhaupt, Frank P ^d  

^a UNIVERSIDAD DEL DESARROLLO   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MANNOSE BINDING LECTIN; MANNOSE BINDING LECTIN 2; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; MBL2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHAGAS DISEASE; CHILD; CHILE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; CHRONIC DISEASE; DISEASE PREDISPOSITION; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; INFANT; INNATE IMMUNITY; METABOLISM; MIDDLE AGED;

TRYPANOSOMA CRUZI;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHAGAS CARDIOMYOPATHY; CHILD; CHILD, PRESCHOOL; CHILE; CHRONIC DISEASE; DISEASE SUSCEPTIBILITY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE; HUMANS; IMMUNITY, INNATE; INFANT; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTOR 4; YOUNG ADULT;

EID: 84856985660     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2012.11-0539     Document Type: Article

References (23)

1. Rassi A Jr, Rassi A, Marin-Neto JA, 2010. Chagas disease. Lancet 375: 1388-1402.
2. Williams-Blangero S, Vandeberg JL, Blangero J, Teixeira AR, 1997. Genetic epidemiology of seropositivity for Trypanosoma cruzi infection in rural Goias, Brazil. Am J Trop Med Hyg 57: 538-543. (Pubitemid 27500456)
3. Cestari I, Krarup A, Sim RB, Inal JM, Ramirez MI, 2009. Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi. Mol Immunol 47: 426-437.
4. Kayama H, Takeda K, 2010. The innate immune response to Trypanosoma cruzi infection. Microbes Infect 12: 511-517.
5. Thiel S, Frederiksen PD, Jensenius JC, 2006. Clinical manifestations of mannan-binding lectin deficiency. Mol Immunol 43: 86-96. (Pubitemid 41021525)
6. Corr SC, O'Neill LA, 2009. Genetic variation in Toll-like receptor signalling and the risk of inflammatory and immune diseases. J Innate Immun 1: 350-357.
7. Luz PR, Miyazaki MI, Neto NC, Nisihara RM,Messias-Reason IJ, 2010. High levels of mannose-binding lectin are associated with the risk of severe cardiomyopathy in chronic Chagas disease. Int J Cardiol 143: 448-450.
8. Ramasawmy R, Cunha-Neto E, Fae KC, Borba SC, Teixeira PC, Ferreira SC, Goldberg AC, Ianni B, Mady C, Kalil J, 2009. Heterozygosity for the S180L variant of MAL/TIRAP, a gene expressing an adaptor protein in the Toll-like receptor pathway, is associated with lower risk of developing chronic Chagas cardiomyopathy. J Infect Dis 199: 1838-1845.
9. AptW, Zulantay I, Solari A, Ortiz S, Oddo D, Corral G, Truyens C, Carlier Y, 2010. Vertical transmission of Trypanosoma cruzi in the Province of Choapa, IV Region, Chile: preliminary report (2005-2008). Biol Res 43: 269-274.
10. AptW, Arribada A, Zulantay I, Solari A, Sanchez G, Mundaca K, Coronado X, Rodriguez J, Gil LC, Osuna A, 2005. Itraconazole or allopurinol in the treatment of chronic American trypanosomiasis: the results of clinical and parasitological examinations 11 years post-treatment. Ann Trop Med Parasitol 99: 733-741. (Pubitemid 41695614)
11. Apt W, Aguilera X, Arribada A, Pérez C, Miranda C, Sánchez G, Zulantay I, Corté s P, Rodriguez J, Juri D, 1998. Treatment of chronic Chagas' disease with itraconazole and allopurinol. Am J Trop Med Hyg 59: 133-138. (Pubitemid 28304810)
12. Schenone H, 1999. Xenodiagnosis. Mem Inst Oswaldo Cruz 94 (Suppl 1): 289-294. (Pubitemid 129584512)
13. Zulantay I, Honores P, SolariA, Apt W, Ortiz S, Osuna A, Rojas A, López B, Sánchez G, 2004. Use of polymerase chain reaction (PCR) and hybridization assays to detect Trypanosoma cruzi in chronic chagasic patients treated with itraconazole or allopurinol. Diagn Microbiol Infect Dis 48: 253-257. (Pubitemid 38519582)
14. Arribada A, AptW,Ugarte JM, 1986. A four-year followup survey of Chagasic cardiopathy in Chile. Bull Pan Am Health Organ 20: 245-266.
15. Hamann L, Hamprecht A, Gomma A, Schumann RR, 2004. Rapid and inexpensive real-time PCR for genotyping functional polymorphisms within the Toll-like receptor -2, -4, and -9 genes. J Immunol Methods 285: 281-291. (Pubitemid 38224568)
16. Johnson CM, Lyle EA, Omueti KO, Stepensky VA, Yegin O, Alpsoy E, Hamann L, Schumann RR, Tapping RI, 2007. Cutting edge: a common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J Immunol 178: 7520-7524. (Pubitemid 46898019)
17. Madsen HO, Garred P, Thiel S, Kurtzhals JA, Lamm LU, Ryder LP, Svejgaard A, 1995. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 155: 3013-3020.
18. Roelofs RW, Sprong T, de Kok JB, Swinkels DW, 2003. PCRrestriction fragment length polymorphism method to detect the X/Y polymorphism in the promoter site of the mannosebinding lectin gene. Clin Chem 49: 1557-1558. (Pubitemid 37011757)
19. Thomas DC, Clayton DG, 2004. Betting odds and genetic associations. J Natl Cancer Inst 96: 421-423.
20. Boldt AB, Luz PR, Messias-Reason IJ, 2011. MASP2 haplotypes are associated with high risk of cardiomyopathy in chronic Chagas disease. Clin Immunol 140: 63-70.
21. Larsen F, Madsen HO, Sim RB, Koch C, Garred P, 2004. Diseaseassociated mutations in human mannose-binding lectin compromise oligomerization and activity of the final protein. J Biol Chem 279: 21302-21311. (Pubitemid 38656537)
22. Khor CC, Chapman SJ, Vannberg FO, Dunne A, Murphy C, Ling EY, Frodsham AJ, Walley AJ, Kyrieleis O, Khan A, Aucan C, Segal S,Moore CE, Knox K, Campbell SJ, Lienhardt C, Scott A, Aaby P, Sow OY, Grignani RT, Sillah J, Sirugo G, Peshu N, Williams TN, Maitland K, Davies RJ, Kwiatkowski DP, Day NP, Yala D, Crook DW, Marsh K, Berkley JA, O'Neill LA, Hill AV, 2007. A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet 39: 523-528. (Pubitemid 46514767)
23. Zafra G, Flórez O, Morillo CA, Echeverría LE,Martín J, González CI, 2008. Polymorphisms of toll-like receptor 2 and 4 genes in Chagas disease. Mem Inst Oswaldo Cruz 103: 27-30. (Pubitemid 351439719)